GCG and type 2 diabetes mellitus: Lastly, our analysis did not control for the presence of being on a GLP‐1 for the primary treatment of type 2 diabetes and only covers the period from 2012 to 2020 before the release of newer effective incretin‐based therapies, such as Semaglutide and Tirzepatide for the indication of weight loss [33, 37].